The Top News Story of 2019, According to Our Readers
We polled our readers to find out which of 5 stories they thought was the most important healthcare story of the year. Here are the results.
This year, The American Journal of Managed Care® asked readers to pick the most important healthcare news story for 2019. Here are the results.
5. A judge strikes down Medicaid work rules in Kentucky and Arkansas.
In March 2019, a US District Court judge in Washington, DC, agreed with plaintiffs who argued that HHS did not act reasonably in allowing Kentucky and Arkansas to create work requirements for beneficiaries to receive healthcare. In separate opinions, the judge said that approval of both programs failed to consider the core purpose of Medicaid—to provide healthcare for the needy. About 18,000 people lost healthcare coverage alone in Arkansas before the program was halted.
4. The uninsured rate hits a 4-year high.
3. Doctors link a mysterious lung illness to vaping.
Over the summer of 2019, teenagers and young adults began presenting to hospitals in multiple states with unusual and severe lung illnesses, and by August, the CDC said it was investigating a “cluster” of such cases. By year’s end,
2. An appeals court brings uncertainty to the future of the ACA.
The Fifth Circuit Court of Appeals, in December 2019, struck down the individual mandate—the heart of the ACA that requires everyone to have health coverage and lays the groundwork for a risk pool that is more balanced between the sick and the healthy, the young and the old. The appeals panel sent the case back to the federal district court in Texas to determine whether other parts of the law, such as provisions to require plans to cover preexisting conditions, are constitutional and can exist without the mandate.
1. Dr. Scott Gottlieb steps down as FDA commissioner.
Although the initial nomination of Scott Gottlieb, MD, to head the agency was met with some criticism, his 2-year tenure at the FDA wound up receiving bipartisan praise, particularly efforts to restructure the drug review process, curb teen vaping, and battle the opioid crisis. Gottlieb returned to the American Enterprise Institute as a resident fellow.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025